In this article, Aptar Pharma uses inductively coupled plasma optical emission spectrometry (ICP-OES) to demonstrate that our proprietary manufacturing process optimizes the distribution of silicone oil on our PremiumCoat®. By limiting the quantity of silicone that comes in contact with the drug product, PremiumCoat® derisks the development of sensitive drugs.
Learn more about PremiumCoat® Platform
This Might Also Be of Interest

Quality, Safety & Regulatory Compliance for Elastomeric Closures
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Approaches to Extractables and Leachables in Parenteral Drugs
Webinars, Pharmaceutical, Market Insights, Product Solutions

Aptar Pharma ETFE Film Coated Syringe Plungers Protect Sensitive Injectables
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Performance of ETFE-Coated Components for Container Closure Integrity
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions